Biomarin Pharmaceutical (BMRN) Q4 2019 Earnings

23OctConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-0.32
-0.11
0.09
0.3

Details

Expected EPS
0.06
Actual EPS
0.3
Surprise EPS
0.24
Surprise Percent
+400%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.3 per share for Q4 2019.

0 Comments

Share your thoughts